~~<i id='966448FC8A'><strike id='966448FC8A'><tt id='966448FC8A'><pre id='966448FC8A'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：hotspot 2025-10-03 00:48:59 Page View：82

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.
Next article： At least 13 dead in Texas as scorching temps continue

explore

Walensky prepares to leave CDC — and Congress — behind

OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

Sophia Smith scores twice for US in in 3

UnitedStates'AlexMorgan(13)andSavannahDeMelo(9)celebrateagoalbyteammateSophiaSmithduringthefirsthalf

In Memoriam: Notable people who died in 2023

1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

New requirements coming in 2024 for Americans traveling to Europe

4:04ThecoverofaU.S.PassportisdisplayedinTigard,Ore.,Dec.11,2021.JennyKane/AP,FILEAnyonelookingtotrav

WSS

explore

explore

knowledge

explore

New requirements coming in 2024 for Americans traveling to Europe